Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
13,807,575
-
Shares change
-
-2,581,030
-
Total reported value, excl. options
-
$17,120,647
-
Value change
-
-$3,739,994
-
Put/Call ratio
-
20%
-
Number of buys
-
33
-
Number of sells
-
-43
-
Price
-
$1.24
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2024
99 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q2 2024.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,807,575 shares
of 43,411,663 outstanding shares and own 32% of the company stock.
Largest 10 shareholders include Bleichroeder LP (2,861,606 shares), Slate Path Capital LP (2,402,455 shares), VANGUARD GROUP INC (2,031,421 shares), BlackRock Inc. (756,736 shares), MILLENNIUM MANAGEMENT LLC (493,987 shares), GEODE CAPITAL MANAGEMENT, LLC (492,456 shares), Robertson Stephens Wealth Management, LLC (478,500 shares), NORTHERN TRUST CORP (350,419 shares), Good Life Advisors, LLC (325,000 shares), and GSA CAPITAL PARTNERS LLP (277,559 shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.